Northwestern Medicine investigators have uncovered new insights into how intercellular "glue" functions to enable ...

You are free to share (copy and redistribute) this article in any medium or format and to adapt (remix, transform, and build upon) the material for any purpose, even commercially within the parameters ...

NEWTON, MA, USA I March 19, 2025 I Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that ...

ABSTRACT: Many infectious diseases are treated with antibiotics and antivirals. But the emergence of antimicrobial-resistant strains and mutant microorganisms has made antimicrobial resistance a major ...

Avidity Biosciences Inc. says will submit an application for accelerated approval to the FDA for del-zota before the end of ...

School of Chemistry and Chemical Engineering, University of Jinan, Jinan 250022, P. R. China Zibo City Engineering Research Center for New Pollution Monitoring and Governance, Shandong Vocational ...

PMN310, the Company’s lead product candidate for the treatment of AD, is a differentiated, humanized monoclonal antibody that ...

Today's Marketplace (TMP) is proud to announce a featured interview with Acumen Pharmaceuticals (NASDAQ: ABOS) CEO Daniel ...

Investigators released the cause of death for Gene Hackman and his wife Betsy Arakawa on Friday. The New Mexico Office of the Medical Investigator says Hackman died from a cardiovascular disease with ...

Rapid Enrollment and Dosing of First Patients Encouraging and Underscores Unmet Need for Better Treatment Options for ...

BUT WE KNOW THERE’S THESE TOXIC AGGREGATES. THEY’RE CALLED OLIGOMERS. THEY CAN START TO FORM MORE THAN A DECADE BEFORE SYMPTOMS APPEAR AND BEFORE OTHER KNOWN DISEASE MARKERS FORM. THE ABILITY ...